These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of anchors on reliability of endoscopic tremor ratings. Lowell SY; Kelley RT; Busekroos L; Voleti R; Hosbach-Cannon CJ; Colton RH; Mihaila D Laryngoscope; 2017 Feb; 127(2):411-416. PubMed ID: 27075631 [TBL] [Abstract][Full Text] [Related]
23. Voice Tremor in Patients with Essential Tremor: Effects of Deep Brain Stimulation of Caudal Zona Incerta. Hägglund P; Sandström L; Blomstedt P; Karlsson F J Voice; 2016 Mar; 30(2):228-33. PubMed ID: 26001501 [TBL] [Abstract][Full Text] [Related]
24. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective. Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922 [TBL] [Abstract][Full Text] [Related]
25. The Effects of Remote Signal Transmission and Recording on Acoustical Measures of Simulated Essential Vocal Tremor: Considerations for Remote Treatment Research and Telepractice. Lester-Smith RA; Jebaily CG; Story BH J Voice; 2024 Mar; 38(2):325-336. PubMed ID: 34702610 [TBL] [Abstract][Full Text] [Related]
26. The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study. Lowell SY; Kelley RT; Monahan M; Hosbach-Cannon CJ; Colton RH; Mihaila D Laryngoscope; 2019 Aug; 129(8):1882-1890. PubMed ID: 30585335 [TBL] [Abstract][Full Text] [Related]
27. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study. Cha W; Jang JY; Wang SG; Kang JH; Jo MG J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509 [TBL] [Abstract][Full Text] [Related]
28. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study. Mendelsohn AH; Berke GS Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926 [TBL] [Abstract][Full Text] [Related]
29. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Courey MS; Garrett CG; Billante CR; Stone RE; Portell MD; Smith TL; Netterville JL Ann Otol Rhinol Laryngol; 2000 Sep; 109(9):819-22. PubMed ID: 11007083 [TBL] [Abstract][Full Text] [Related]
30. Development of a speech treatment program for a client with essential vocal tremor. Barkmeier-Kraemer J; Lato A; Wiley K Semin Speech Lang; 2011 Feb; 32(1):43-57. PubMed ID: 21491358 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin injections for essential voice tremor. Hertegård S; Granqvist S; Lindestad PA Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):204-9. PubMed ID: 10685574 [TBL] [Abstract][Full Text] [Related]
32. Increased stability of airflow following botulinum toxin injection. Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837 [TBL] [Abstract][Full Text] [Related]
34. Multiparametric laryngeal assessment of the effect of thalamic deep brain stimulation on essential vocal tremor. Erickson-DiRenzo E; Kuijper FM; Barbosa DAN; Lim EA; Lin PT; Lising MA; Huang Y; Sung CK; Halpern CH Parkinsonism Relat Disord; 2020 Dec; 81():106-112. PubMed ID: 33120071 [TBL] [Abstract][Full Text] [Related]
35. Impact of patient-related factors on the outcomes of office-based injection laryngoplasty. Sardesai MG; Merati AL; Hu A; Birkent H Laryngoscope; 2016 Aug; 126(8):1806-9. PubMed ID: 26597519 [TBL] [Abstract][Full Text] [Related]
36. Bilateral Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus Improves Objective Acoustic Measures of Essential Vocal Tremor. Patel R; Burroughs L; Higgins A; Zauber SE; Isbaine F; Schneider D; Hohman R; Gupta K Neurosurgery; 2024 Oct; 95(4):915-923. PubMed ID: 38787392 [TBL] [Abstract][Full Text] [Related]
37. [Voice change and acoustic character of essential voice tremor]. Wang L; Dong J; Chen X; Wang T Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):817-9. PubMed ID: 17144486 [TBL] [Abstract][Full Text] [Related]
38. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia. Sanuki T; Takemoto N Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482 [TBL] [Abstract][Full Text] [Related]
39. Treatment of ventricular dysphonia with botulinum toxin. Kendall KA; Leonard RJ Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137 [TBL] [Abstract][Full Text] [Related]
40. Multidimensional Analysis on the Effect of Vocal Function Exercises on Aged Vocal Fold Atrophy. Kaneko M; Hirano S; Tateya I; Kishimoto Y; Hiwatashi N; Fujiu-Kurachi M; Ito J J Voice; 2015 Sep; 29(5):638-44. PubMed ID: 25944293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]